Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Autoimmune Market Outlook to' returned 126 results - Page 1 of 7   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases   Decision Resources, Inc., July 2009, Pages: 43 - Factors Holding Back the Autoimmune and Infl ammatory Disease Industry Industry Outlook Tables 1. Decision Resources Analysts’ Input on the Current Status and Future Directions of Autoimmune The 2011-2016 World Outlook for Autoimmune Disease Therapeutics   ICON Group International, Jan 2011, Pages: 195 Samoa 9 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 9.1 Disclaimers & Safe Harbor 9.2 Icon Group International, Inc. User Agreement Provisions The 2011-2016 World Outlook for Autoimmune The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Greater China   ICON Group International, Jan 2011, Pages: 142 Financial Services, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “autoimmune disease therapeutics” is established. In the case of this report The 2011-2016 Outlook for Autoimmune Disease Therapeutics in India   ICON Group International, Jan 2011, Pages: 319 Monetary Fund, Euromonitor, Mintel, Thomson Financial Services, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “autoimmune disease therapeutics The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Japan   ICON Group International, Jan 2011, Pages: 141 , the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “autoimmune disease therapeutics” is established. In the case of this report, the data were The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Africa   ICON Group International, Jan 2011, Pages: 56 3 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 3.1 Disclaimers & Safe Harbor 3.2 Icon Group International, Inc. User Agreement Provisions The 2011-2016 Outlook for Autoimmune Disease The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Asia   ICON Group International, Jan 2011, Pages: 38 -2016 Outlook for Autoimmune Disease Therapeutics in Asia The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Europe & the Middle East   ICON Group International, Jan 2011, Pages: 71 . User Agreement Provisions The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Europe & the Middle East The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Latin America   ICON Group International, Jan 2011, Pages: 35 Harbor 3.2 Icon Group International, Inc. User Agreement Provisions The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Latin America The 2011-2016 Outlook for Autoimmune Disease Therapeutics in North America & the Caribbean   ICON Group International, Jan 2011, Pages: 37 , AND USER AGREEMENT PROVISIONS 3.1 Disclaimers & Safe Harbor 3.2 Icon Group International, Inc. User Agreement Provisions The 2011-2016 Outlook for Autoimmune Disease Therapeutics in North America The 2011-2016 Outlook for Autoimmune Disease Therapeutics in Oceana   ICON Group International, Jan 2011, Pages: 34 .25 Western Samoa 3 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 3.1 Disclaimers & Safe Harbor 3.2 Icon Group International, Inc. User Agreement Provisions The 2011-2016 Outlook for Autoimmune The 2011-2016 Outlook for Autoimmune Disease Therapeutics in the United States   ICON Group International, Jan 2011, Pages: 731 Financial Services, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “autoimmune disease therapeutics” is established. In the case of this report Chinese Markets for Autoimmune Drugs   AMID Co., Feb 2009, Pages: 168 Imports and Exports Autoimmune Drugs Imports Autoimmune Drugs Exports Pricing Trends V. AUTOIMMUNE DRUGS MARKET OUTLOOK Autoimmune Drugs Markets Outlook Overview Government Regulation Health Care Special Report: The Autoimmune Biologics Pipeline-A Competitive Review   Decision Resources, Inc., Aug 2011 Maintenance Therapies with Sustained Long-Term Efficacy for Moderate to Severe Disease Market Statistics and Market Outlook Autoimmune Biologics Market Statistics Autoimmune Biologics Market Outlook Autoimmune Disease Therapeutics   Greystone Associates, Sep 2009, Pages: 130 Growth --Competitive Landscape -Autoimmune Therapeutic Market Assessments --Arthritis ---Key Approved Therapies ---Drugs in Development ---Commercial Outlook --Crohn's Disease ---Current Treatment Immune/Inflammatory Disease: Early-Stage R&D Technologies and Dealmaking   Decision Resources, Inc., May 2009, Pages: 24 Profi les Archemix Array BioPharma Cellzome Dynavax Regulus Therapeutics Outlook Tables 1. Descriptions of Inflammatory and Autoimmune Diseases 2. Top-Selling Autoimmune and Anti-Inflammatory Strategic Overview of the Autoimmune Biologics Market   Decision Resources, Inc., Sep 2011 Specialists’ Patient Populations and Biologics Prescribing Habits Scope of This Section Agents in Development Companies Market Statistics and Market Outlook Autoimmune Biologics Market Statistics What Strategies Will Yield Novel Treatments for Autoimmune Disease?   Decision Resources, Inc., March 2008, Pages: 26 , has greatly improved the treatment outlook for some of the more common autoimmune diseases. These agents have significant drawbacks, however, including side effects and high costs. Pharmaceutical Autoimmune Disease Therapeutics - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2011, Pages: 749 Techniques & Analytics 3 Product Definition and Scope of Study 3 Rheumatoid Arthritis 4 Multiple Sclerosis 4 Psoriasis 4 Crohns disease 4 2. INDUSTRY OVERVIEW & OUTLOOK 5 Autoimmune Disease Autoimmune Disease Series: Will Biologics Emerge as New Treatments for Reactive Arthritis?   Decision Resources, Inc., Dec 2008, Pages: 26 arthritis: TNF-a inhibitors, emerging biologic therapies - Outlook for reactive arthritis market: 2007 sales, outlook for emerging therapies - This report is part of the Autoimmune Disease Series: In 2007 Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network